EPHA2 displays a complex expression pattern in CRC patients, with greater expression in CRC stages 1 and 2 than in stages 3 and 4, with marked down-regulation in metastatic cases [26, 46]. This evidence concerns the gene EPHA2 and colorectal carcinoma.